2.250GBp+28.57%Mkt Cap: 3.75M GBpP/E: —Last update: 2026-06-01
BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.75M GBp
Enterprise Value38.19K GBp
Revenue (TTM)52.84K GBp
Gross Profit-18.16K GBp
Net Income (TTM)-1.11M GBp
Revenue/Share0.0050 GBp
Last Price2.250 GBp
Fiscal Year EndSep 2025
MR QuarterSep 2025
Employees14
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.03
EV/Revenue0.72
P/S55.27
P/B0.07
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.000056% of range4.000
52W High4.000 GBp
52W Low0.0000 GBp
Profitability
Gross Margin-34.37%
Oper. Margin-1099.44%
EBITDA Margin0.00%
Profit Margin-2107.36%
ROE-40.97%
ROA-37.03%
Growth
Revenue Growth815.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.01M GBp
CapEx (TTM)10.35K GBp
FCF Margin-1208.59%
FCF Yield-17.01%
Net Debt-149.02K GBp
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity0.00
Current Ratio1.70
Quick Ratio1.38
Book Value/Sh0.2540 GBp
Cash/Share0.0140 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateFeb 27, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.166.87M
Float7.35M
Insiders22.75%
Institutions0.03%
Technical
SMA 501.600 (+40.7%)
SMA 2002.083 (+8.0%)
Beta3.59
S&P 52W Chg27.94%
Avg Vol (30d)7.59M
Avg Vol (10d)5.45M
Technical Indicators
RSI (14)53.5
MACD0.0251
MACD Signal0.0271
MACD Hist.-0.0021
BB Upper1.963 GBp
BB Middle1.715 GBp
BB Lower1.468 GBp
BB Width28.86%
ATR (14)0.5706 GBp
Vol Ratio (20d)0.53x